51. Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood
- Author
-
Miri Lutski, Boris Fishman, Zohar Levi, Dana Ben-Ami Shor, Amir Tirosh, Zivan Beer, Tali Cukierman-Yaffe, Gilad Twig, Michal Ben-Ami, Dorit Tzur, Aya Bardugo, Hans-Ulrich Häring, Inbar Zucker, Arnon Afek, Itamar Raz, Cole D. Bendor, Hertzel C. Gerstein, Estela Derazne, Orit Pinhas-Hamiel, and Ofri Mosenzon
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Population ,030209 endocrinology & metabolism ,Context (language use) ,Type 2 diabetes ,Biochemistry ,Body Mass Index ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Non-alcoholic Fatty Liver Disease ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Nonalcoholic fatty liver disease ,medicine ,Humans ,030212 general & internal medicine ,Age of Onset ,Israel ,Young adult ,education ,Adolescence ,Nafld ,Type 2 Diabetes ,Young Adults ,education.field_of_study ,business.industry ,Incidence ,Incidence (epidemiology) ,Biochemistry (medical) ,Hazard ratio ,medicine.disease ,Diabetes Mellitus, Type 2 ,Case-Control Studies ,Female ,business ,Follow-Up Studies - Abstract
Context The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear. Objective To assess type 2 diabetes risk among adolescents with NAFLD. Design and Setting A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997–2011 and were followed until December 31, 2016. Participants A total of 1 025 796 normoglycemic adolescents were included. Interventions Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry. Main Outcome Measures Type 2 diabetes incidence. Results During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47–4.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]). Conclusions Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.
- Published
- 2020